capecitabine plus either neratinib or lapatinib for patients with her2 breast cancer
Published 2 years ago • 247 plays • Length 5:33Download video MP4
Download video MP3
Similar videos
-
3:27
her2 de novo mbc: neratinib vs lapatinib plus capecitabine
-
1:31
results for neratinib plus capecitabine in her2 breast cancer brain metastases
-
1:02
dr. freedman on neratinib plus capecitabine for cns disease from her2-positive breast cancer
-
7:25
neratinib capecitabine in her2 breast cancer
-
7:38
tucatinib plus trastuzumab & capecitabine for patients with her2-positive breast cancer & brain mets
-
3:31
pyrotinib plus capecitabine for her2 metastatic breast cancer
-
2:08
dr. jagielska on long-term survival with lapatinib plus capecitabine in her2 breast cancer
-
6:17
tesetaxel plus reduced-dose capecitabine among patients with hr /her2- metastatic breast cancer
-
2:35
tucatinib with capecitabine and trastuzumab in advanced her2-positive breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
3:15
neratinib for metastatic breast cancer
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
7:30
neratinib plus fulvestrant for her2 mutant, non-amplified metastatic breast cancer
-
8:47
sramila aithal, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
0:49
systemic therapies shown to be effective in her2-positive breast cancer
-
3:27
tesetaxel plus capecitabine for patients with metastatic breast cancer
-
9:35
neratinib in her2 breast cancer
-
1:09
latest updates in her2-positive metastatic breast cancer: the nala and sophia trials
-
3:54
practical advice on using neratinib for r/r her2 mbc